Shared horizons: Optimising drug response to improve patient outcomes

Rydges Lakeland Resort, Queenstown, New Zealand from 25 – 29 November 2019

ASCEPT-PAGANZ 2019 Joint Scientific Meeting

READ MORE

Want to become a member
and enjoy the benefits?

JOIN ASCEPT

BENEFITS

Want to know about our
long term plans

READ OUR STATEGIC PLAN

We list career opportunities within the
Pharmaceutical and Toxicology
industries, and related fields

Looking for a job?

CAREER OPPORTUNITIES

LIST A POSITION

Australian Society of Clinical and Experimental Pharmacology and Toxicology

ASCEPT was founded in 1966, and held its first scientific meeting a year later. Since that time, ASCEPT has developed into the peak professional society devoted to advancing excellence in Clinical and Experimental Pharmacology and Toxicology in Australasia.

Latest News

NEWS CENTRE

Twitter Feed

Drugs that are commonly overprescribed in primary care include amoxicillin+clavulanate, cefalexin, cefaclor, erythromycin, and roxithromycin. Download your copy of the up-to-date summary table for first-line treatments in primary care http://bit.ly/TGSummary

Science communicator. Television presenter. Children's author. Biologist. We’re absolutely thrilled to introduce @Constababble as MC for the #SmP2019 Gala Dinner 🤩 Just 5 days to go!

This year #ASCEPTPAGANZ2019 is getting more techie & social!
📳Download 'The Event App by EventsAIR' app in your phone, enter ascept-paganz as event code. Use the conference app to build your agenda and contact attendees.
🤳🏽Get social on Twitter to make it fun and win 💰 prizes!

Prof Amin Rostami from @Certara who is the @BritPharmSoc visitor to @ASCEPTanz braves the Adelaide 42C heat to present on “Endogenous Biomarkers and Precision Dosing ” today #AdelaidePharmacologyGroup #MID3 #PBPK #BraveTheHeat

Load More...

Upcoming Events

ASCEPT-PAGANZ 2019 Joint Scientific Meeting

Rydges Lakeland Resort, Queenstown, New Zealand
25 – 29 November 2019

Call for abstracts + registration opens
Monday 15 April
Abstract submission deadline
Monday 9 September
Early bird registration deadline + accommodation booking deadline
Monday 21 October

SUPPORTING MEMBER COLLABORATION

ASCEPT members have many diverse interests and so have formed Special Interest Groups to acknowledge these strengths, to enhance the cohesion of the Society and to promote and advance the study and application of pharmacology and toxicology in its broadest context. Currently, there are SIGs in the following areas.

Respiratory and Inflammation

The Respiratory & Inflammation SIG aims to facilitate cutting edge research in the areas of respiratory and inflammatory diseases.

Clinical Pharmacology

Clinical Pharmacology involves all aspects of safe, effective and rational use of medicines in humans (individual, group, or population levels).

Cardiovascular

The Cardiovascular SIG (formed in 2008) aims to foster collaboration and exchange of ideas across all areas of cardiovascular research.

Drug Disposition and Response

Drug Disposition and Response involves the distribution, metabolism and excretion of drug and the relationship between drug concentrations and effects.

Drug Discovery

Education Forum

A conduit for the sharing of ideas and resources between those involved in pharmacology education, with the overall aim of ensuring that all students of pharmacology receive a quality education that prepares them for their future careers.

Pharmacogenomics

The Pharmacogenomics SIG addresses molecular mechanisms, clinical impact and public health implications of genomics affecting drug response and adverse effects.

Student Forum

The Student Forum is currently under construction and will be available in the near future.

New Zealand Forum

To provide an annual forum to promote and disseminate pharmacology & toxicology research, clinical practice and education within New Zealand and beyond

Toxicology

Open to all who have an interest in toxicology. Including but not limited to drugs, medicines and consumer product toxicity, pesticides and agrichemicals, nanomaterials, occupational chemicals and industrial pollutants, naturally occurring toxic chemicals and poisons, poisoning management and clinical toxicity.

Urogenital and Gastrointestinal

The Urogenital/Gastrointestinal SIG promotes research in the field of urogenital and gastrointestinal
pharmacology and disseminate findings to Australian researchers while encouraging early career
researchers with opportunities to present their work.

Neuropharmacology

The Neuropharmacology and behavioural SIG is interested in how drugs affect cellular activity within the nervous system and how this influences behaviour.

Pharmacoepidemiology

The role of the Pharmacoepidemiology SIG is to promote and support pharmacoepidemiological research and collaboration within ASCEPT members.

ASCEPT

BOARD AND COMMITTEE

Professor Carl Kirkpatrick

President

Faculty of Pharmacy & Pharmaceutical Sciences, Monash University

Dr Danijela Gnjidic

President Elect

School of Pharmacy, Faculty of Medicine and Health, The University of Sydney

Professor Emilio Badoer

Treasurer

Medical Sciences, RMIT University

Dr Betty Exintaris

Board/Company Secretary

Faculty of Pharmacy & Pharmaceutical Sciences, Monash University

PARTNERS & SPONSORS

Certara
JPS
AMH